JTCS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Harold L. Lazar
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lazar, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lazar, H. L.

J Thorac Cardiovasc Surg 2003;125:974-975
© 2003 The American Association for Thoracic Surgery


Letters to the Editor

Quinaprilat during cardioplegic arrest

Harold L. Lazar, MD

Professor of Cardiothoracic Surgery, Boston Medical Center, Cardiothoracic Surgery, Boston, MA 02118

To the Editor:

I read with interest the recent article by Korn and his coworkersGo 1 concerning quinaprilat during cardioplegic arrest to prevent ischemia-reperfusion injury. They have demonstrated that quinaprilat enhances recovery of the ischemic myocardium and suggests that its protective mechanism may be due to the increased coronary blood flow during the early reperfusion period. My group at the Boston Medical Center has recently published a study that helps to identify the mechanisms for the beneficial effects of quinaprilat.Go 2

In an intact porcine model involving ischemia and reperfusion with cardioplegic arrest on cardiopulmonary bypass, hearts treated with the high-affinity tissue angiotensin-converting enzyme (ACE) inhibitor quinaprilat had significantly better recovery of regional wall motion, a lower incidence of ventricular arrhythmias, and a smaller infarct size than controls. When the low-affinity tissue ACE inhibitor enalaprilat was administered, the decrease in infarct size was less (24% enalaprilat vs 14% quinaprilat; P < .0001). The beneficial effects of quinaprilat's action could be explained by its superior preservation of endothelial function, since quinaprilat-treated hearts had significantly greater coronary arterial relaxation in response to bradykinin (66% quinaprilat vs 32% enalaprilat; P < .0001). When the bradykinin antagonist HOE140 was added to the quinaprilat-treated hearts, the protective effect on endothelial function was abolished and these hearts had a significant increase in infarct size (48% quinaprilat + HOE vs 14% quinaprilat; P < .0001).

I agree that ACE inhibitors enhance myocardial protection during cardioplegic arrest. However, ACE inhibitors are not all equally protective. ACE inhibitors with high tissue ACE inhibition such as quinaprilat result in better preservation of endothelial function, which decreases ischemic necrosis. This improvement in endothelial function appears to be bradykinin-mediated. I concur with Korn and coworkers that high-affinity tissue ACE inhibitors may play an important role in enhancing cardioplegic protection during coronary revascularization.Go Go 2,3

References

  1. Korn P, Kröner A, Schirnhofer J, Hallström S, Bernecker O, Mallinger R, et al. Quinaprilat during cardioplegic arrest in the rabbit to prevent ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 2002;124:352-60.[Abstract/Free Full Text]
  2. Lazar HL, Bao Y, Rivers S, Colton S, Bernard SA. High tissue affinity angiotensin-converting enzyme inhibitors improve endothelial function and reduce infarct size. Ann Thorac Surg. 2001;72:548-54.[Abstract/Free Full Text]
  3. Lazar HL, Bao Y, Rivers S, Bernard SA. Pretreatment with angiotensin-converting inhibitors attenuates ischemic reperfusion injury during coronary revascularization. Ann Thorac Surg. 2002;73:1522-7.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Harold L. Lazar
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lazar, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lazar, H. L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS